A Novel Scaffold to Promote Skin Regeneration

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41AR070681-01A1
Agency Tracking Number: R41AR070681
Amount: $225,000.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: NIAMS
Solicitation Number: PA16-303
Timeline
Solicitation Year: 2016
Award Year: 2017
Award Start Date (Proposal Award Date): 2017-09-14
Award End Date (Contract End Date): 2019-08-31
Small Business Information
300 WEST COLEMAN BOULEVARD SUITE 203, Mount Pleasant, SC, 29464-5641
DUNS: 602545654
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 HOWARD LEVINSON
 (843) 388-3276
 howard.levinson@duke.edu
Business Contact
 GAUTAM GHATNEKAR
Phone: (843) 860-8785
Email: ghatnekar@firststringresearch.com
Research Institution
 DUKE UNIVERSITY
 2200 W MAIN ST, SUITE 820
DURHAM, NC, 27705-4673
 Nonprofit college or university
Abstract
PROJECT SUMMARY Dermal scarring affects more than million people worldwide annually over million people are injured in motor vehicle accidents over million patients are severely burned and thousands of warriors are wounded in military blasts In severe burns more than of patients develop hypertrophic scar contraction which leads to hypertrophic scar contractures HSc HSc are stiff shrunken scars that limit mobility impact quality of life and cost millions of dollars per year in surgical treatment and physical therapy HSc are caused by increased mechanical tension and occur months after injury Current tissue engineered scaffolds such as IntegraTM have mechanical properties akin to unwounded skin but the collagen based scaffolds rapidly degrade over months being too short lived to prevent HSc The key to preventing HSc is having a biocompatible scaffold which degrades over months To achieve this goal the development of scaffolds composed of viscoelastic copolymer poly lactide co caprolactone PLCL is proposed Published work has demonstrated that electrospun m thick PLCL scaffolds possess appropriate mechanical properties for implantation beneath skin grafts and inhibition of HSc in mice However electrospinning cannot be used to generate scaffolds at thickness necessary for large animal studies due to the great voltage gradient required for scaffold production To overcome this hurdle solvent casting particulate leaching SCPL will be used to create D porous PLCL scaffolds This method involves the mixing of polymers with particles within an organic solvent followed by casting into a mold Water is then passed through the mold to leach out the particles resulting in an interconnected porous D scaffold This SPCL method has successfully been used to create mm thick PLCL scaffolds which have appropriate mechanical properties and tunable porosity for implantation beneath skin grafts We hypothesize that optimized SCPL PLCL scaffolds will promote graft bioincorporation and dampen fibrosis in vivo The three Aims to test our hypothesis are Aim Determine SCPL manufacturing parameters to create uniform PLCL scaffolds with controlled pore size porosity and mechanical properties Aim Determine the optimal porosity of collagen coated SCPL PLCL scaffolds for tissue ingrowth Aim Evaluate the safety and efficacy of optimal porosity PLCL scaffolds at promoting skin graft survival The completion of these aims will validate a scalable method to create PLCL scaffolds and test them in rodent and swine wound models for safety and efficacy The results will bring us closer toward developing an optimized technology that prevents HSc with the potential to improve millions of lives worldwide PROJECT NARRATIVE Scarring is a significant medical problem that affects more than million people worldwide annually and can have many etiologies Currently available skin substitutes for wound healing have suboptimal degradation rates leading to the formation of hypertrophic scars that limit mobility impact quality of life and cost millions of dollars per year in surgical treatment and physical therapy This work will create and validate a unique degradable scaffold with a prolonged degradation rate that promotes graft bioincorporation and prevents hypertrophic scarring

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government